Author response
J Clin Sleep Med
.
2020 Apr 15;16(4):645-646.
doi: 10.5664/jcsm.8298.
Authors
Po-Lan Su
1
2
,
Cheng-Yu Lin
2
3
,
Sheng-Hsiang Lin
4
5
6
Affiliations
1
Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
2
Sleep Medicine Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
3
Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
4
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
5
Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
6
Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
PMID:
32022676
PMCID:
PMC7161461
DOI:
10.5664/jcsm.8298
Abstract
Su P-L, Lin C-Y, Lin S-H. Author response.
J Clin Sleep Med
. 2020;16(4):645–646.
Publication types
Letter
Comment
MeSH terms
Adrenergic Agents
Cohort Studies
Humans
Publishing*
Research Design
Sleep Apnea Syndromes*
Substances
Adrenergic Agents